MedTrace Logo

Almond Butter and Fasting Glucose

NCT03826472 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-04-09

Study results available
· View outcomes & findings →

Summary

A two-period randomized crossover study will be conducted to determine the effect of almond butter as an evening snack on fasting blood glucose in adults with type 2 diabetes, not taking insulin.

Conditions

  • Type2 Diabetes

Interventions

OTHER

Almond Butter

Natural almond butter

Sponsors & Collaborators

  • Penn State University

    lead OTHER

Principal Investigators

  • Penny M Kris-Etherton, PhD, RDN · Penn State

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-08
Primary Completion
2020-03-01
Completion
2020-03-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03826472 on ClinicalTrials.gov